Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumors Rebecca LiuDuane A. Mitchell Review 16 September 2009 Pages: 183 - 193
Multimer technologies for detection and adoptive transfer of antigen-specific T cells Rosaely Casalegno-GarduñoAnita SchmittMichael Schmitt Review 22 October 2009 Pages: 195 - 202
Loci controlling lymphocyte production of interferon γ after alloantigen stimulation in vitro and their co-localization with genes controlling lymphocyte infiltration of tumors and tumor susceptibility Marie LipoldováHelena HavelkováPeter Demant Original Article Open access 05 August 2009 Pages: 203 - 213
Systemic dysregulation of CEACAM1 in melanoma patients Gal MarkelRona OrtenbergJacob Schachter Original Article 25 July 2009 Pages: 215 - 230
Antibody to CCDC104 is associated with a paraneoplastic antibody to CDR2 (anti-Yo) Cecilie TotlandGeir BredholtChristian A. Vedeler Original Article 14 August 2009 Pages: 231 - 237
Assessment of the pre-clinical immunogenicity of a new VEGF receptor Fc-fusion protein FP3 with ELISA and BIACORE Hui WangJing ShiDechao Yu Original Article 25 July 2009 Pages: 239 - 246
Dynamic monitoring the TCR CDR3 spectratypes in patients with metastatic CRC treated with a combination of bevacizumab, irinotecan, fluorouracil, and leucovorin Wei LuoWang-Jun LiaoXiao-Ning Wang Original Article 04 August 2009 Pages: 247 - 256
A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies Pina M. CardarelliChetana Rao-NaikDavid J. King Original Article 06 August 2009 Pages: 257 - 265
Tumors induce the formation of suppressor endothelial cells in vivo Jennifer Konopa MulliganM. Rita I. Young Original Article 09 August 2009 Pages: 267 - 277
The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy Xia WuQin-Mei FengWen Di Original Article 30 August 2009 Pages: 279 - 291
A phase II trial of intraperitoneal interleukin-2 in patients with platinum-resistant or platinum-refractory ovarian cancer Anda M. VladRaluca A. BudiuRobert P. Edwards Original Article 19 August 2009 Pages: 293 - 301
Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis? Marna G. BouwhuisAndreas GastRajiv Kumar Original Article Open access 12 August 2009 Pages: 303 - 312
Autophagy facilitates major histocompatibility complex class I expression induced by IFN-γ in B16 melanoma cells Bo LiZhang LeiBo Huang Original Article 13 August 2009 Pages: 313 - 321
Immune impairment in patients with terminal cancers: influence of cancer treatments and cytomegalovirus infection I-Hsuan ChenYuen-Liang LaiYen-Ta Lu Original Article 15 August 2009 Pages: 323 - 334
Impact of Cytomegalovirus infection on immune signatures in cancer patients Evelyna Derhovanessian Letter to the editor 17 September 2009 Pages: 335 - 336
Response to Dr Derhovanessian “Impact of cytomegalovirus infection on immune signatures in cancer patients” Yen-Ta LuI-Hsuan Chen Letter to the editor 04 November 2009 Pages: 337 - 337
Erratum to: Amyloid precursor-like protein 2 association with HLA class I molecules Amit TuliMahak SharmaJoyce C. Solheim Erratum 13 October 2009 Pages: 339 - 339